C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2004
12/09/2004	WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	WO2004094388A3 Indazole derivatives as jnk inhibitors
12/09/2004	WO2004087699A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004087698A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004071440A3 Thiazolyl-based compounds useful as kinase inhibitors
12/09/2004	WO2004061084A8 Modulation of protein functionalities
12/09/2004	WO2004018478A3 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/09/2004	WO2003080582A3 Fredericamycin derivatives
12/09/2004	US20040249150 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/09/2004	US20040248950 Apo ai expression accelerating agent
12/09/2004	US20040248945 Thiazolidinedione derivative and its use as antidiabetic
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248934 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands
12/09/2004	US20040248890 Voltage gated sodium and calcium channel inhibitors
12/09/2004	US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
12/09/2004	US20040248851 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	US20040248225 Luciferin hydrazides
12/09/2004	CA2527731A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
12/09/2004	CA2527174A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
12/09/2004	CA2527159A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	CA2526749A1 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
12/08/2004	EP1484328A1 Derivatives of quinolyl-propyl-piperidine and their use as antimicrobial agents
12/08/2004	EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483262A1 Coumarines useful as biomarkers
12/08/2004	EP1483260A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
12/08/2004	EP1483259A1 Pyrimidines as novel openers of potassium ion channels
12/08/2004	EP1483251A1 C3-cyano epothilone derivatives
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482935A1 Thiazole and oxazole derivatives which modulate ppar activity
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1339403B1 Repinotan kit
12/08/2004	EP1218370B1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP0915868B1 Carbanilides used as pesticides
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553907A Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient
12/08/2004	CN1178937C Preparation of intermediate for thiazolylisopseudoindole dyes
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178665C Water soluble prodrugs of azole compounds
12/08/2004	CN1178663C Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
12/08/2004	CN1178657C Treatment and prophylaxis of pancreatitis
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
12/07/2004	US6828344 Direct inhibition of the activity of phospholipase A2 has been suggested as a useful mechanism for a therapeutic agent for inflammation
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828340 Especially for cancer which has developed a multidrug-resistant phenotype.
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828317 Bactericides; gramnegative, grampositive bacteria
12/07/2004	US6828116 Energy transfer assay method and reagent
12/07/2004	CA2272136C Pyrazole derivatives having crf antagonist activity
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2112331C Novel naphthalene derivatives
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004103999A1 AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT
12/02/2004	WO2004103998A1 Quinoline derivatives as phosphodiesterase inhibitors
12/02/2004	WO2004103997A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS PPAR-α ACTIVATORS
12/02/2004	WO2004103995A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
12/02/2004	WO2004103981A1 Process for preparing a 4,7-bis(5-halothien-2-yl)-2,1,3-benzothiadiazole and a precursor therefor
12/02/2004	WO2004103980A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	WO2004103367A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor
12/02/2004	WO2004076413A3 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	WO2004066952A3 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242668 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
12/02/2004	US20040242666 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242660 Combinations of oxazolidinones with other active ingredients for the prophylaxis and/or treatment of thromboembolic disorders
12/02/2004	US20040242658 Recrystallizing rosiglitazone maleate from solvent; for treatment or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and complication thereof in a mammal
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242637 drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004	US20040242602 Novel thiazolidine compounds as calcium sensing receptor modulators
12/02/2004	US20040242593 Cannabinoid derivatives, methods of making, and use thereof
12/02/2004	US20040242580 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242576 Urea substituted benzothiazoles
12/02/2004	US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242573 Novel compounds
12/02/2004	US20040242571 Novel benzothiazine derivatives, their preparation and use

1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 628